DE60310708D1 - In vivo stabilsierung von plasmiden - Google Patents

In vivo stabilsierung von plasmiden

Info

Publication number
DE60310708D1
DE60310708D1 DE60310708T DE60310708T DE60310708D1 DE 60310708 D1 DE60310708 D1 DE 60310708D1 DE 60310708 T DE60310708 T DE 60310708T DE 60310708 T DE60310708 T DE 60310708T DE 60310708 D1 DE60310708 D1 DE 60310708D1
Authority
DE
Germany
Prior art keywords
plasmid
methods
host cells
vivo
maintaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60310708T
Other languages
English (en)
Other versions
DE60310708T2 (de
Inventor
Julian Hanak
Rocky Cranenburgh
Scott Gorman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cobra Biologics Ltd
Original Assignee
Cobra Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cobra Biologics Ltd filed Critical Cobra Biologics Ltd
Publication of DE60310708D1 publication Critical patent/DE60310708D1/de
Application granted granted Critical
Publication of DE60310708T2 publication Critical patent/DE60310708T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60310708T 2002-05-18 2003-05-19 In vivo stabilsierung von plasmiden Expired - Lifetime DE60310708T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0211459.3A GB0211459D0 (en) 2002-05-18 2002-05-18 Plasmid stabilisation in vivo
GB0211459 2002-05-18
PCT/GB2003/002166 WO2003097838A1 (en) 2002-05-18 2003-05-19 Plasmid stabilisation in vivo

Publications (2)

Publication Number Publication Date
DE60310708D1 true DE60310708D1 (de) 2007-02-08
DE60310708T2 DE60310708T2 (de) 2007-10-31

Family

ID=9936960

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60310708T Expired - Lifetime DE60310708T2 (de) 2002-05-18 2003-05-19 In vivo stabilsierung von plasmiden

Country Status (11)

Country Link
EP (1) EP1507863B1 (de)
AT (1) ATE349539T1 (de)
AU (1) AU2003232336A1 (de)
DE (1) DE60310708T2 (de)
DK (1) DK1507863T3 (de)
ES (1) ES2279963T3 (de)
GB (1) GB0211459D0 (de)
PT (1) PT1507863E (de)
SI (1) SI1507863T1 (de)
WO (1) WO2003097838A1 (de)
ZA (1) ZA200410202B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2684749T3 (es) 2004-08-13 2018-10-04 The Trustees Of The University Of Pennsylvania Métodos para construir vacunas sin resistencia a antibióticos
AU2005271247A1 (en) * 2004-08-13 2006-02-16 The Trustees Of The University Of Pennsylvania Antibiotic resistance free DNA vaccines
KR101719833B1 (ko) * 2009-05-22 2017-03-24 메리얼 인코포레이티드 항생제-미함유 플라스미드
CA2889069C (en) 2012-10-15 2021-01-26 University Of Maryland, Baltimore Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518395D0 (en) * 1995-09-08 1995-11-08 Therexsys Ltd Plasmid stabilization
US6780405B1 (en) * 2000-04-28 2004-08-24 Avant Immunotherapeutics, Inc. Regulated antigen delivery system (RADS)

Also Published As

Publication number Publication date
EP1507863B1 (de) 2006-12-27
DK1507863T3 (da) 2007-05-07
ATE349539T1 (de) 2007-01-15
PT1507863E (pt) 2007-03-30
AU2003232336A1 (en) 2003-12-02
GB0211459D0 (en) 2002-06-26
SI1507863T1 (sl) 2007-06-30
ZA200410202B (en) 2006-08-30
DE60310708T2 (de) 2007-10-31
ES2279963T3 (es) 2007-09-01
EP1507863A1 (de) 2005-02-23
WO2003097838A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
ES2768976T3 (es) Edición de genoma mediada por nucleasa
CY1122059T1 (el) Μεθοδος τροποποιησης ευκαρυωτικων κυτταρων
TR201909609T4 (tr) Modifiye edilmiş nükleosidleri içeren rna ve kullanım yöntemleri.
DE60330841D1 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
DE69636032D1 (de) Plasmid zur verabreichung von nukleine säuren und verwendungsverfahren
CY1111060T1 (el) Νουκλεϊκα οξεα χρησιμα για την πυροδοτηση της θνησιμοτητας κυτταρων ογκου
ATE332388T1 (de) Methoden zur modifikation eukaryotischer zellen
ATE440950T1 (de) Konstrukte und verfahren zur regulation der genexpression
TNSN07087A1 (en) Stable liquid formulations of plasmid dna
Razin et al. Nuclear matrix attachment regions and topoisomerase II binding and reaction sites in the vicinity of a chicken DNA replication origin
WO2003076561A3 (en) Recombinase fusion protein with enhanced cellular uptake
DK1526840T3 (da) Nanopartikler til DNA administration til et målorgan
DE60310708D1 (de) In vivo stabilsierung von plasmiden
ATE513033T1 (de) Expression von proteinen in aus nabelschnurblut gewonnenen endothelzellen
WO2005034876A3 (en) Use of cell lines to produce active therapeutic proteins
DE60129069D1 (de) Hepatitis B Virus Vektoren für Gentherapie
HUP0101355A2 (hu) Fehérjetermelésre és célba juttatására szolgáló genomi szekvenciák
WO2003090778A3 (en) Dna vaccine combined with an inducer of tumor cell apoptosis
SI1673391T1 (sl) Modificirana cDNA za visoke ekspresijske nivoje faktorja VIII in njegovih derivatov
DE60002603D1 (de) Phosphor-enthaltende dendrimere als transfektionsagente
RS104404A (en) Control sequences of the human corin gene
ATE315406T1 (de) Semi-allogene antitumor-vakzine mit hla-haplo- identischen antigen-präsentierenden zellen
WO2004001027A8 (en) Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof
WO2002068629A3 (en) Dna constructs for cytoplasmic and mithochondrial expression and methods of making and using same
Toth et al. 691. A Light-Inducible CRISPR/Cas9 System for Control of Endogenous Gene Activation

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: HANAK, JULIAN, KEELE ST5 5SP, GB

Inventor name: CRANENBURGH, ROCKY, KEELE ST5 5SP, GB

Inventor name: GORMAN, SCOTT, OXFORD OX4 4GA, GB

8364 No opposition during term of opposition